CPT1A and neoplasm: Moreover, restoring ASCL2 or CPT1A expression in FAT1 KO SCC1 cells not only counteracted the reduction in cell proliferation and clonogenicity mediated by FAT1 KO (Figure S6, Supporting Information), but also reversed the inhibition of tumor growth in an orthotopic mouse model (Figure S7, Supporting Information).